Research Paper Volume 15, Issue 21 pp 12451—12475
Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction
Figure 3. Biological features of LUAD patients in the stratified SFTPC subgroups. (A–H) Examples of GSEA results of LUAD patients with high (A–D) and low (E–H) expression of SFTPC.